OtherBasic Science (Animal or Phantoms)
Discovery of [18F]PSMA-7, a novel PET-probe for the detection of small PSMA positive lesions
Boris D. Zlatopolskiy, Heike Endepols, Philipp Krapf, Mehrab Guliyev, Elizaveta A. Urusova, Raphael Richarz, Melanie Hohberg, Markus Dietlein, Alexander E. Drzezga and Bernd Neumaier
Journal of Nuclear Medicine November 2018, jnumed.118.218495; DOI: https://doi.org/10.2967/jnumed.118.218495
Boris D. Zlatopolskiy
1 University Hospital of Cologne, Germany;
Heike Endepols
2 Institute of Radiochemistry and Experimental Molecular Imaging, Germany;
Philipp Krapf
3 Research Centre Jülich, Germany;
Mehrab Guliyev
1 University Hospital of Cologne, Germany;
Elizaveta A. Urusova
3 Research Centre Jülich, Germany;
Raphael Richarz
1 University Hospital of Cologne, Germany;
Melanie Hohberg
1 University Hospital of Cologne, Germany;
Markus Dietlein
4 Universitätsklinikum Köln, Germany
Alexander E. Drzezga
1 University Hospital of Cologne, Germany;
Bernd Neumaier
3 Research Centre Jülich, Germany;
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
Discovery of [18F]PSMA-7, a novel PET-probe for the detection of small PSMA positive lesions
Boris D. Zlatopolskiy, Heike Endepols, Philipp Krapf, Mehrab Guliyev, Elizaveta A. Urusova, Raphael Richarz, Melanie Hohberg, Markus Dietlein, Alexander E. Drzezga, Bernd Neumaier
Journal of Nuclear Medicine Nov 2018, jnumed.118.218495; DOI: 10.2967/jnumed.118.218495
Discovery of [18F]PSMA-7, a novel PET-probe for the detection of small PSMA positive lesions
Boris D. Zlatopolskiy, Heike Endepols, Philipp Krapf, Mehrab Guliyev, Elizaveta A. Urusova, Raphael Richarz, Melanie Hohberg, Markus Dietlein, Alexander E. Drzezga, Bernd Neumaier
Journal of Nuclear Medicine Nov 2018, jnumed.118.218495; DOI: 10.2967/jnumed.118.218495
Jump to section
Related Articles
Cited By...
- Intraindividual Comparison of 18F-PSMA-1007 with Renally Excreted PSMA Ligands for PSMA PET Imaging in Patients with Relapsed Prostate Cancer
- An 18F-Labeled PSMA Ligand for PET/CT of Prostate Cancer: First-in-Humans Observational Study and Clinical Experience with 18F-JK-PSMA-7 During the First Year of Application
- Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes